: Quarterly results In Q3/2017, the Company and its subsidiary recorded total sales of Baht 1,500 million, a decrease of 15% YoY due to the slowdown in domestic branded and export CMG sales. However, export
period of the prior year 0.33 baht million or 29.60%, due to the following reasons as follows; 1. Total incomes of the Company increases 40.53 million baht or 139.57% against to the same period of prior
Classification : ใชภ้ายใน (Internal) Toolkits to support business towards achieving the SDGs Human Rights Due Diligence Handbook for Small and Medium-Sized Enterprises Human Rights Due Diligence Training Facility
, due to the following reasons; 1. Total incomes of the Company increase to THB 122.90 million equal to 73.59% against to the same period of last year mainly due to: 1.1) Revenue from Sales increase THB
%, due to the following reasons as follows; 1. Total incomes of the Company increases to 119.47 million baht equal to 67.86% against to the same period of last year mainly due to: 1.1) Revenue from Sales
. Income from medical treatments in the consolidated financial Statement went up 6.81% due to income from Chiang Mai Ram Medical Business Plc.”CMR”, a subsidiary amount Baht 3,747.64 million went up from
, due to the following reasons as follows; 1. Total incomes of the Company increase to 167.24 million baht equal to 240.37% against to the same period of last year mainly due to: 1.1) Revenue from Sales
24.41%, due to the following reasons as follows; 1. Total income of the Company increases 71.16 million baht or 74.24% compare with the same period of prior year mainly due to: 1.1) Revenue from selling
the follow main reasons. 1. Revenue from hospital operations increased by Baht 102.22 million or 4.52 % due to in 2018 the general patients of Company and subsidiaries increased. 2. Cost of hospital
% because of the follow main reasons. 1. Revenue from hospital operations increased by Baht 52.43 million or 8.94 % due to in Q3/2018 the revenue from general patient increased. 2. Cost of hospital operations